You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GEP-NET

Showing 1 - 25 of 692
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

68Ga-DOTATOC Radio-Guided Surgery With ß-Probe in GEP-NET

Recruiting
  • Neuroendocrine Tumor Carcinoid
  • +2 more
    • Milan, Italy
      IRCCS Istituto Europeo di Oncologia S.r.l.
    Jul 8, 2022

    Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

    Recruiting
    • Gastroenteropancreatico Tumors
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    Lutathera® in Somatostatin Receptor Positive

    Recruiting
    • Somatostatin Receptor-positive GEP-NET
    • Lutathera
    • Seongnam Si, Gyeonggi Do, Korea, Republic of
    • +4 more
    Jun 29, 2022

    GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

    Recruiting
    • GEP-NET
    • +6 more
    • Duarte, California
    • +3 more
    Jul 28, 2022

    GEP-NET Trial in Taiwan (nanoliposomal irinotecan plus carboplatin)

    Not yet recruiting
    • GEP-NET
    • nanoliposomal irinotecan plus carboplatin
    • Kaohsiung, Taiwan
    • +5 more
    May 17, 2022

    GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

    Enrolling by invitation
    • GEP-NET
    • +3 more
    • Copenhagen, Denmark
      Rigshospitalet
    Jan 24, 2023

    Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

    Not yet recruiting
    • Small Cell Lung Cancer (SCLC)
    • +3 more
    • (no location specified)
    Dec 7, 2022

    Neuroendocrine Neoplasia's (NENs), Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) Trial in Basel (161Tb-DOTA-LM3,

    Not yet recruiting
    • Neuroendocrine Neoplasia's (NENs)
    • Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
    • Basel, Switzerland
      Division of Nuclear Medicine, University Hospital Basel
    Apr 27, 2022

    Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))

    Suspended
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Stanford, California
      Stanford Cancer Institute Palo Alto
    Sep 21, 2022

    Pulmonary Neuroendocrine Tumor, Pheochromocytoma, Paraganglioma Trial in Houston (177Lu-DOTATOC)

    Recruiting
    • Pulmonary Neuroendocrine Neoplasm
    • +9 more
    • Houston, Texas
      Excel Diagnostics and Nuclear Oncology Center
    Jul 9, 2021

    Gastroenteropancreatic Neuroendocrine Tumors, Pheochromocytoma, Paraganglioma Trial in Worldwide (Lutetium [177Lu]

    Recruiting
    • Gastroenteropancreatic Neuroendocrine Tumors
    • +2 more
    • Lutetium [177Lu] oxodotreotide/dotatate
    • Iowa City, Iowa
    • +16 more
    Apr 6, 2022

    Metastatic Well Differentiated Neuroendocrine Tumor, Neuroendocrine Tumors Trial in Milano (Cabozantinib, Lanreotide)

    Recruiting
    • Metastatic Well Differentiated Neuroendocrine Neoplasm
    • Neuroendocrine Tumors
    • Milano, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Sep 3, 2021

    Neuroendocrine Tumor, Liver Metastases, Neuroendocrine Gastroenteropancreatic Tumour Trial in France (Positron emission

    Recruiting
    • Neuroendocrine Tumor
    • +2 more
    • Positron emission tomography computed tomography (PET/CT) with Intra-hepatic (IAH) injection
    • +3 more
    • Bordeaux, France
    • +3 more
    Nov 18, 2021

    Gastro-Enteropancreatic Neuroendocrine Tumor Trial in Austria, Denmark, United States (Satoreotide trizoxetan 5-20µg,

    Completed
    Has Results
    • Gastro-Enteropancreatic Neuroendocrine Tumor
    • Satoreotide trizoxetan 5-20μg
    • Satoreotide trizoxetan 30-45μg
    • Los Angeles, California
    • +4 more
    Jan 8, 2021

    Acromegaly, GEP-NET Trial in Worldwide (Debio 4126, Sandostatin LAR, Somatuline ATG)

    Recruiting
    • Acromegaly
    • GEP-NET
    • Debio 4126
    • +2 more
    • Copenaghen, Denmark
    • +34 more
    Jan 27, 2023

    United Kingdom Patient Preference Study of Somatuline Autogel

    Completed
    • Neuroendocrine Tumours (NET)
      • Birmingham, United Kingdom
      • +4 more
      Jul 5, 2022

      Neuroendocrine Tumors Trial in Milano (Y90-DOTA-Tyr3-Octreotide)

      Completed
      • Neuroendocrine Tumors
      • Milano, Italy
        Chiara Maria Grana
      Mar 3, 2020

      Gastroenteropancreatic Neuroendocrine Tumors Trial in Basel (satoreotide trizoxetan)

      Completed
      Has Results
      • Gastroenteropancreatic Neuroendocrine Tumors
      • satoreotide trizoxetan
      • Basel, Switzerland
        University Hospital Basel
      Sep 5, 2019

      Well-differentiated Non-functional NET of Thoracic Origin, Well-differentiated Non-functional NET of Gastrointestinal Origin,

      Completed
      Has Results
      • Well-differentiated Non-functional NET of Thoracic Origin
      • +3 more
      • Duarte, California
      • +34 more
      Mar 16, 2021

      Gastro-entero Pancreatic Neuroendocrine Tumors Trial in Italy

      Recruiting
      • Gastro-entero Pancreatic Neuroendocrine Tumors
        • Rozzano, Milan, Italy
        • +35 more
        Oct 27, 2022

        Nutrition in Gastroenteropancreatic Neuroendocrine Tumor

        Active, not recruiting
        • Gastroenteropancreatic Neuroendocrine Tumor
          • El Palmar, Murcia, Spain
          • +15 more
          Feb 16, 2022

          Chromogranin A as Blood Marker in Cancer Patients

          Completed
          • Gastric Neoplasms
          • +3 more
          • BRAHMS CgA II KRYPTOR
          • Palo Alto, California
          • +3 more
          Dec 19, 2022

          Neuroendocrine Tumor, Gastroenteropancreatic Trial in Milano (Surgery)

          Active, not recruiting
          • Neuroendocrine Tumor
          • Gastroenteropancreatic
          • Surgery
          • Milano, Italy
            San Raffaele Hospital IRCCS
          May 5, 2022

          Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)

          Not yet recruiting
          • Advanced Gastroenteropancreatic Neuroendocrine Tumor
          • (no location specified)
          Oct 16, 2023

          Neuroendocrine Tumors,Gastroenteropancreatic Trial in Taipei (Cabozantinib, Lanreotide)

          Not yet recruiting
          • Neuroendocrine Tumors,Gastroenteropancreatic
          • Taipei, Taiwan
            National Taiwan University Hospital
          Sep 9, 2021